Breast Cancer Clinical Trials in Chicago, IL

Breast Cancer Clinical Trials in Chicago, IL

View the best 10 breast cancer medical studies in Chicago, Illinois. Access promising new therapies by applying to a Chicago-based Breast Cancer clinical trial.

Trials in Chicago, Illinois

Here are the top 10 medical studies for breast cancer in Chicago, Illinois

Image of USC Norris Comprehensive Cancer Center in Los Angeles, United States.

PC14586 +1 More

Small Molecule

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Image of University of Illinois Chicago in Chicago, United States.

Taking Charge during Treatment (TCT) Intervention

Recruiting1 award
This trial is looking at how cancer drugs impact the vascular system and whether or not exercise can help offset some of those changes.
Image of University of Illinois Cancer Center in Chicago, United States.

Alpelisib

PI3K Inhibitor

Recruiting1 awardPhase 2
This trial is for patients with late-stage breast cancer who have a specific genetic mutation. They will take a daily drug (alpelisib) in combination with a standard cancer treatment. The trial will follow patients to see how well they respond to the new drug.
Image of City of Hope Medical Center in Duarte, United States.

Bazedoxifene +1 More

Selective Estrogen Receptor Modulator (SERM)

Recruiting1 awardPhase 2
This trial tests a combination of two medications, bazedoxifene and conjugated estrogens, in women at risk for breast cancer who also have menopausal hot flashes. The treatment aims to reduce these symptoms and possibly lower cancer risk. Researchers will compare changes in breast tissue and hormone levels over several months between those taking the medication and those who are not. Bazedoxifene paired with conjugated estrogens is the first combination approved by the FDA for treating menopausal symptoms.
Image of Northwestern University in Chicago, United States.

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 1
This trial is investigating the side effects of two drugs, cabozantinib and nivolumab, in treating patients with advanced cancer who are also undergoing treatment for HIV.
Image of University of Chicago Medical Center in Chicago, United States.

Pharmacogenomics (PGx) Testing and Genomics Prescribing Information (GPS)

Genetic Testing

Recruiting1 award2 criteria
This trial will test whether providing genetic information to cancer care providers helps them to make better decisions about chemotherapy dosing and reduces side effects.
Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

Decision Aid

Recruiting1 award22 criteria
This trial is testing web-based tools to help patients with early stage breast cancer make decisions about treatment. The goal is to learn how best to implement these tools in clinical practice.
Image of Palo Verde Hematology Oncology in Glendale, United States.

Capecitabine +2 More

Antimetabolites

Recruiting2 awardsPhase 3
This trial will test if a new combination of drugs is more effective and safer than standard treatments for triple negative breast cancer.
Image of Texas Oncology - Baylor Charles A. Sammons Cancer Center in Dallas, United States.

Capecitabine +3 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial will compare the effectiveness of two treatments for HR+/HER2- breast cancer in terms of progression-free survival.
Image of Research Site in Jonesboro, United States.

Durvalumab +2 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial tests the effectiveness and safety of new treatments for TNBC and hormone receptor-low/HER2-negative breast cancer.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.